North America Vascular Graft Market Size, Share, and COVID-19 Impact Analysis, By Product (Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, and Peripheral Vascular Grafts), By Application (Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, and Coronary Artery Disease), and North America, Vascular Graft Market Insights, Industry Trend, Forecasts to 2035

North America Vascular Graft Market Insights Forecasts to 2035

• The North America Vascular Graft Market Size Was Estimated at USD 1.04 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of Around 3.75% from 2025 to 2035
• The North America Vascular Graft Market Size is Expected to Reach USD 1.56 Billion by 2035

According to a Research Report Published by Spherical Insights & Consulting, The North America Vascular Graft Market Size is anticipated to reach USD 1.56 Billion by 2035, Growing at a CAGR of 3.75% from 2025 to 2035. The increasing healthcare expenditure, availability of reimbursement policies, and growing demand for technologically advanced products are poised to create numerous opportunities for North America vascular graft market.   

Market Overview

The industry devoted to the creation, manufacturing, and distribution of synthetic and biological vascular grafts used in medical operations to treat coronary artery disorders, vascular occlusion, and aneurysms is known as the North America vascular graft market. It includes peripheral vascular grafts, coronary artery bypass grafts, endovascular stent grafts, and hemodialysis access grafts. The market for vascular grafts in North America presents opportunities due to factors such as growing biocompatible graft material acceptance, rising desire for less invasive operations, rising prevalence of cardiovascular disease, and expanding healthcare infrastructure. The region rise in vascular illnesses, such as aneurysms, chronic kidney disease (CKD), coronary artery disease (CAD), and peripheral artery disease (PAD), is a major driver of the North America vascular graft market. Owing to their capacity to lower the danger of neointimal development, prosthetic grafts such as electrospun polyurethane vascular grafts are widely used for complex vascular trauma, which is expected to drive the North America vascular graft market. The creation of next-generation tissue-engineered vascular grafts to treat a variety of vasculopathies is being driven by technological developments.   

Report Coverage

This research report categorizes the market size for North America Vascular Graft Market Size based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the North America vascular graft market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the North America vascular graft market. 

Driving Factors

The high incidence of abdominal aneurysms, the aging population, and the rising frequency of smoking and other risk factors that encourage aneurysms are the primary factors driving the North America vascular graft market. The rising prevalence of heart disease, diabetes, end-stage renal disease (ESRD), and vascular occlusions are major factor propelling the growth of the North America vascular graft market. Growth in the market is being driven by improvements in vascular graft designs and scaffold materials, as well as the increasing prevalence of cardiovascular illnesses. The increased need for effective treatment alternatives and the expanding focus on minimally invasive procedures are contributing to the extensive use of vascular grafts in the North America market.

Restraining Factors

High prices, strict regulatory clearances, graft failure risks, restricted reimbursement policies, and biocompatibility issues are some of the barriers preventing widespread adoption and market growth in the North America vascular graft market. 

Market Segmentation

The North vascular graft market share is classified into product and application.

• The endovascular stent grafts segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

The North America vascular graft market is segmented by product into hemodialysis access grafts, endovascular stent grafts, coronary artery by-pass grafts, vascular grafts for aorta disease, and peripheral vascular grafts. Among these, the endovascular stent grafts segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. A fabric tube held aloft by a metal mesh stent is called an endovascular stent graft. Thoracic and abdominal aortic aneurysms belong to the many blood vessel disorders for which these grafts are frequently utilized. 

• The cardiac aneurysm segment held a largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The North America vascular graft market is segmented by application into cardiac aneurysm, kidney failure, vascular occlusion, and coronary artery disease. Among these, the cardiac aneurysm segment held a largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The cardiac aneurysm segment, which is characterized by bulges in the walls of blood vessels, usually arteries, mostly affects the aorta, which is in charge of carrying oxygenated blood from the heart to the body. Both coronary artery aneurysms and abdominal aortic aneurysms (AAA), which affect many people, are covered in this section.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the North America vascular graft market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott
• Cook Group
• Cardinal Health
• B. Braun SE
• Becton, Dickinson and Company
• Others

Recent Developments

• In July 2024, in partnership with Cornell University, Anova Biomedical received a Manufacturing Grant from FuzeHub. Through addressing manufacturing scalability and improving accessibility for healthcare providers, the funding will help the scaling of production for novel materials and vascular grafts, promoting greater acceptance of these advanced vascular grafts in medical applications. 

Key Target Audience 

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at North America, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the North America vascular graft market based on the below-mentioned segments:

North America Vascular Graft Market, By Product

• Hemodialysis Access Grafts
• Endovascular Stent Grafts
• Coronary Artery By-Pass Grafts
• Vascular Grafts for Aorta Disease
• Peripheral Vascular Grafts

North America Vascular Graft Market, By Application

• Cardiac Aneurysm
• Endovascular Stent Graft
• Vascular Graft
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Disease